A short history of monoclonal antibody research in Cambridge – Abzena

A short history of monoclonal antibody research in Cambridge

19 April 2017

Abzena’s CEO John Burt features in this short film by Cambridge TV. It leads us through a short history of monoclonal antibody research in the Cambridge life science cluster and asks what the next big thing will be in this area of exciting medical technology. John talks on the benefits of  antibody drug conjugates and bispecifics in being better able to address the underlying biology of the disease.

Interested in our services? Get In Touch